受强制性开放获取政策约束的文章 - Vijay Ramakrishnan了解详情
可在其他位置公开访问的文章：16 篇
Sorafenib, a dual Raf kinase/vascular endothelial growth factor receptor inhibitor has significant anti-myeloma activity and synergizes with common anti-myeloma drugs
V Ramakrishnan, M Timm, JL Haug, TK Kimlinger, LE Wellik, TE Witzig, ...
Oncogene 29 (8), 1190-1202, 2010
强制性开放获取政策： US National Institutes of Health
Bortezomib combination therapy in multiple myeloma
P Kapoor, V Ramakrishnan, SV Rajkumar
Seminars in hematology 49 (3), 228-242, 2012
强制性开放获取政策： US National Institutes of Health
TG101209, a novel JAK2 inhibitor, has significant in vitro activity in multiple myeloma and displays preferential cytotoxicity for CD45+ myeloma cells
V Ramakrishnan, T Kimlinger, J Haug, M Timm, L Wellik, T Halling, ...
American journal of hematology 85 (9), 675-686, 2010
强制性开放获取政策： US National Institutes of Health
MRK003, a γ-secretase inhibitor exhibits promising in vitro pre-clinical activity in multiple myeloma and non-Hodgkin's lymphoma
V Ramakrishnan, S Ansell, J Haug, D Grote, T Kimlinger, M Stenson, ...
Leukemia 26 (2), 340-348, 2012
强制性开放获取政策： US National Institutes of Health
Anti-myeloma activity of Akt inhibition is linked to the activation status of PI3K/Akt and MEK/ERK pathway
V Ramakrishnan, T Kimlinger, J Haug, U Painuly, L Wellik, T Halling, ...
PloS one 7 (11), e50005, 2012
强制性开放获取政策： US National Institutes of Health
Clinical use and applications of histone deacetylase inhibitors in multiple myeloma
N Tandon, V Ramakrishnan, SK Kumar
Clinical pharmacology: advances and applications, 35-44, 2016
强制性开放获取政策： US National Institutes of Health
Inhibitor of apoptosis proteins as therapeutic targets in multiple myeloma
V Ramakrishnan, U Painuly, T Kimlinger, J Haug, SV Rajkumar, S Kumar
Leukemia 28 (7), 1519-1528, 2014
强制性开放获取政策： US National Institutes of Health
Glutamine-derived 2-hydroxyglutarate is associated with disease progression in plasma cell malignancies
WI Gonsalves, V Ramakrishnan, T Hitosugi, T Ghosh, D Jevremovic, ...
JCI insight 3 (1), 2018
强制性开放获取政策： US National Institutes of Health
Sorafenib, a multikinase inhibitor, is effective in vitro against non‐hodgkin lymphoma and synergizes with the mTOR inhibitor rapamycin
V Ramakrishnan, M Timm, JL Haug, TK Kimlinger, T Halling, LE Wellik, ...
American journal of hematology 87 (3), 277-283, 2012
强制性开放获取政策： US National Institutes of Health
Microarray analysis of gene expression changes in feeding female and male lone star ticks, Amblyomma americanum (L)
MN Aljamali, VG Ramakrishnan, H Weng, JS Tucker, JR Sauer, ...
Archives of Insect Biochemistry and Physiology: Published in Collaboration …, 2009
强制性开放获取政策： US National Institutes of Health
Histone deacetylase inhibition in combination with MEK or BCL-2 inhibition in multiple myeloma
VG Ramakrishnan, KC Miller, EP Macon, TK Kimlinger, J Haug, S Kumar, ...
Haematologica 104 (10), 2061, 2019
强制性开放获取政策： US National Institutes of Health
Smac mimetic LCL161 overcomes protective ER stress induced by obatoclax, synergistically causing cell death in multiple myeloma
V Ramakrishnan, M Gomez, V Prasad, T Kimlinger, U Painuly, ...
Oncotarget 7 (35), 56253, 2016
强制性开放获取政策： US National Institutes of Health
Multiple mechanisms contribute to the synergistic anti-myeloma activity of the pan-histone deacetylase inhibitor LBH589 and the rapalog RAD001
V Ramakrishnan, T Kimlinger, M Timm, J Haug, SV Rajkumar, S Kumar
Leukemia research 38 (11), 1358-1366, 2014
强制性开放获取政策： US National Institutes of Health
In vitro and ex vivo gene expression profiling reveals differential kinetic response of HSPs and UPR genes is associated with PI resistance in multiple myeloma
AK Mitra, H Kumar, V Ramakrishnan, L Chen, L Baughn, S Kumar, ...
Blood cancer journal 10 (7), 78, 2020
强制性开放获取政策： US National Institutes of Health
Natriuretic peptides, inflammation, and sounding the alarm
V Ramakrishnan, JC Burnett Jr
Circulation: Heart Failure 13 (7), e007208, 2020
强制性开放获取政策： US National Institutes of Health
Aurora kinase and FGFR3 inhibition results in significant apoptosis in molecular subgroups of multiple myeloma
U Painuly, V Ramakrishnan, T Kimlinger, L Wellik, J Haug, W Gonsalves, ...
Oncotarget 9 (77), 34582, 2018
强制性开放获取政策： US National Institutes of Health
出版信息和资助信息由计算机程序自动确定